Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Adaptimmune Therapeutics Plc ADR’s stock clocked out at $0.51, down -5.43% from its previous closing price of $0.54. In other words, the price has decreased by -$5.43 from its previous closing price. On the day, 1.39 million shares were traded.
Ratios:
To gain a deeper understanding of ADAP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 3.85. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 30, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On May 30, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $3.15.
On March 24, 2023, Bryan Garnier started tracking the stock assigning a Buy rating and target price of $3.60.Bryan Garnier initiated its Buy rating on March 24, 2023, with a $3.60 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 17 ’25 when Norry Elliot sold 5,584 shares for $0.58 per share. The transaction valued at 3,243 led to the insider holds 7,510 shares of the business.
Lunger John sold 5,584 shares of ADAP for $3,243 on Jan 17 ’25. The Chief Patient Supply Officer now owns 7,510 shares after completing the transaction at $0.58 per share. On Jan 17 ’25, another insider, Bertrand William C JR, who serves as the Chief Operating Officer of the company, sold 5,584 shares for $0.58 each. As a result, the insider received 3,243 and left with 7,510 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 1.63.
Stock Price History:
Over the past 52 weeks, ADAP has reached a high of $2.05, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -13.05%, while the 200-Day Moving Average is calculated to be -41.78%.
Shares Statistics:
A total of 255.70M shares are outstanding, with a floating share count of 226.47M. Insiders hold about 11.49% of the company’s shares, while institutions hold 37.29% stake in the company.
